SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?


To: All Mtn Ski who wrote (477)5/12/2000 11:57:00 AM
From: 993racer  Respond to of 548
 
I guess if Oxygent worked out Baxter might want to purchase ALLP outright...

Anyway...great news, just waiting for news on Imagent NDA , Oxygent, Liquivent NDA filings...



To: All Mtn Ski who wrote (477)5/12/2000 3:11:00 PM
From: aknahow  Respond to of 548
 
I like ALLP and think Baxter is a great partner. Just think it is important to read the agreements with care to have a good understanding of what is involved. Appears to me that thus far no milestones are involved. Baxter is committed to buy more convertible preferred as clinical trials progress.

Will be interesting to see what type of broad guidance ALLP provides on royalties and share of profits.